16 septembre 2024
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1158/2159-8290.CD-24-0018
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/39270324
info:eu-repo/semantics/OpenAccess
Grégoire Gessain et al., « Trem2-expressing multinucleated giant macrophages are a biomarker of good prognosis in head and neck squamous cell carcinoma », HAL SHS (Sciences de l’Homme et de la Société), ID : 10.1158/2159-8290.CD-24-0018
Patients with head and neck squamous cell carcinomas (HNSCC) often havepoor outcomes due to suboptimal risk management and treatment strategies;yet integrating novel prognostic biomarkers into clinical practice is challenging. Here, we reportthe presence of multinucleated giant cells (MGC)—a type of macrophages—in tumors from patientswith HNSCC, which are associated with a favorable prognosis in treatment-naive and preoperativechemotherapy–treated patients. Importantly, MGC density increased in tumors following preoperative therapy, suggesting a role of these cells in the antitumoral response. To enable clinical translationof MGC density as a prognostic marker, we developed a deep-learning model to automate its quantification on routinely stained pathological whole slide images. Finally, we used spatial transcriptomicand proteomic approaches to describe the MGC-related tumor microenvironment and observed anincrease in central memory CD4 T cells. We defined an MGC-specific signature resembling to TREM2-expressing mononuclear tumor-associated macrophages, which colocalized in keratin tumor niches.